Standard and Hypofractionated Dose Escalation to Intraprostatic Tumor Nodules in Localized Prostate Cancer: Efficacy and Toxicity in the DELINEATE Trial

The American Urological Association Symptom Index for Benign Prostatic Hyperplasia

Michael J. Barry, Floyd J. Fowler, Michael P. O’Leary et al. · The Journal of Urology · 1992 · 3.4K citations

Urological Research, Urology, Outcomes Research +8

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference

Mack Roach, Gerald E. Hanks, Howard D. Thames et al. · International Journal of Radiation Oncology*Biology*Physics · 2006 · 2.7K citations

Radiation Medicine, Urology, Radiation Therapy +8

Prospective comparison of faecal incontinence grading systems

C. J. Vaizey, E. Carapeti, Joseph A. Cahill et al. · Gut · 1999 · 1.3K citations · Full text

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

David P. Dearnaley, Isabel Syndikus, Helen Mossop et al. · The Lancet Oncology · 2016 · 1.3K citations · Full text

A New Measure of Health Status for Clinical Trials in Inflammatory Bowel Disease

Alba Mitchell, E. Jan Irvine, Joel Singer et al. · Gastroenterology · 1989 · 1.2K citations · Full text

Epidemiology, Functional Gastrointestinal Disorder, New Measure +9